Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs

Int J Mol Sci. 2024 Apr 9;25(8):4161. doi: 10.3390/ijms25084161.

Abstract

Neuroinflammation and epilepsy are different pathologies, but, in some cases, they are so closely related that the activation of one of the pathologies leads to the development of the other. In this work, we discuss the three main cell types involved in neuroinflammation, namely (i) reactive astrocytes, (ii) activated microglia, and infiltration of (iii) peripheral immune cells in the central nervous system. Then, we discuss how neuroinflammation and epilepsy are interconnected and describe the use of different repurposing drugs with anti-inflammatory properties that have been shown to have a beneficial effect in different epilepsy models. This review reinforces the idea that compounds designed to alleviate seizures need to target not only the neuroinflammation caused by reactive astrocytes and microglia but also the interaction of these cells with infiltrated peripheral immune cells.

Keywords: astrocytes; epilepsy; microglia; neuroinflammation; peripheral immune cells; repurposing drugs; seizures.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Anticonvulsants / pharmacology
  • Anticonvulsants / therapeutic use
  • Astrocytes* / drug effects
  • Astrocytes* / metabolism
  • Drug Repositioning* / methods
  • Epilepsy* / drug therapy
  • Humans
  • Microglia* / drug effects
  • Microglia* / metabolism
  • Neuroinflammatory Diseases* / drug therapy

Substances

  • Anti-Inflammatory Agents
  • Anticonvulsants